ESLAW stock · TER stock

ESLAW vs TER

Estrella Immunopharma Inc. (ESLAW) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.

Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.

Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.

ESLAW does not have a complete income-statement cache yet.

Latest reported TER revenue for 2026-06-28 was $2.61B. Net income was $773.4M. TER currently screens at market cap $63.96B and trailing P/E 75.7.

ESLAW currently screens at market cap $0. TER currently screens at market cap $63.96B and trailing P/E 75.7.

Not investment advice. Open the ESLAW and TER stock pages for the full models.

Not investment advice.

Popular Stock Comparisons